Interim 4th cohort results should stem the bleeding on the SP and get their CR all filled. Seems to be a lot of people on edge regarding the short term prospects of the SP. If their trials are successful whether you bought at 3, 4, 5, or even 9 cents will be irrelevant. People who get angry or stressed by a pretty obvious price drop from a 1 for every 2 share CR shouldn't be investing in these type of bio stocks. And if you have all your money in Bio stocks then be prepared that some investments won't come through. It is a very risky sector. Still a long term buy IMO.
PAB Price at posting:
5.6¢ Sentiment: LT Buy Disclosure: Held
